Biomarker based treatment selection in cancer

Important results from the project

The goal of this Vinnova project was further development of our MS-based diagnostic test. In the project, we have experimentally optimized and validated final reagents and MS methods to be used in the test, and applied the diagnostic test to clinical samples. In parallel, we have developed a complementary stand-alone kit for sample preparation so that the quality of samples analyzed with the diagnostic test can be guaranteed. Finally, we have begun the development of software for the analysis, interpretation and reporting of the diagnostic test.

Expected long term effects

The result of the project is that we have moved closer to clinical use of our diagnostic test. During the project, we have also strengthened our business strategy and our product protection, established contacts with sub-suppliers and strategic customers and raised capital to ensure continued development of our products. Overall, the project has brought the company and our products to a position where we can attract new investors required for the next stage of our business development.

Approach and implementation

The development of the diagnostic test has been carried out during the project in close collaboration with the academic group in which the founders of the company are active. This has been a direct necessity since the development is dependent on instrumentation and systems that are not available in the company. Development of sample preparation kits and software has taken place within the company with the help of subcontractors. The work has generally progressed according to plan, although with some delays mainly due to the pandemic.